Downtrend on the daily chart: below its 50- and 200-day averages · 50-day above the 200-day · SuperTrend down since Aug 4 · below the Ichimoku cloud · RSI 25 (oversold) · MACD below its signal
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $536.4K | 0.00% | 14.30K | −23% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a XRN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 16, 2026 | Whitlock Matthew FitzsimmonsChief Investment Officer | Purchase at price 36.38 - 37.21 per share. | 1K | $36.80K |
| Aug 10, 2026 | Fitzgerald Charles James JrDirector | Purchase at price 35.78 per share. | 14K | $500.92K |
| Aug 10, 2026 | Decker Mark Okey JrChief Executive Officer | Purchase at price 36.00 per share. | 550 | $19.80K |
| Aug 10, 2026 | Decker Mark Okey JrChief Executive Officer | Purchase at price 35.92 per share. | 6.9K | $246.95K |
| Aug 9, 2026 | Fitzgerald Charles James JrDirector | Purchase at price 35.94 per share. | 27.6K | $991.94K |
| Aug 9, 2026 | Decker Mark Okey JrChief Executive Officer | Purchase at price 35.88 per share. | 8K | $287.04K |
| May 13, 2026 | Cypher Matthew L Ph.D.Director | Purchase at price 35.12 per share. | 1.4K | $49.87K |
| May 11, 2026 | Marston RonaldDirector | Purchase at price 34.04 - 34.14 per share. | 1.5K | $51.11K |
| May 11, 2026 | Holley DanicaChief Operating Officer | Purchase at price 33.99 per share. | 1.5K | $50.65K |
| May 11, 2026 | Barber Jamie AllenGeneral Counsel | Purchase at price 33.50 per share. | 1.5K | $49.61K |
| May 11, 2026 | Wittman Lori BDirector | Purchase at price 33.85 per share. | 2.9K | $99.52K |
| May 11, 2026 | Decker Mark Okey JrChief Executive Officer | Purchase at price 33.74 - 33.99 per share. | 5K | $169.70K |
| May 10, 2026 | Cole HenryDirector | Purchase at price 33.36 - 34.32 per share. | 583 | $20.00K |
| May 10, 2026 | Crowley PaulaDirector | Purchase at price 34.00 per share. | 1K | $34.00K |
| May 10, 2026 | Kiernan Robert JChief Financial Officer | Purchase at price 33.49 per share. | 3K | $100.47K |
| Dec 4, 2025 | Decker Mark Okey JrChief Executive Officer | Purchase at price 32.51 per share. | 10K | $325.10K |
| Nov 13, 2025 | Kiernan Robert JChief Financial Officer | Purchase at price 31.91 per share. | 3K | $95.73K |
| Nov 13, 2025 | Decker Mark Okey JrChief Executive Officer | Purchase at price 32.41 - 32.70 per share. | 10K | $325.81K |
| Aug 25, 2025 | Cypher Matthew L Ph.D.Director | Purchase at price 7.38 per share. | 1.4K | $9.96K |
| Aug 14, 2025 | Barber Jamie AllenGeneral Counsel | Sale at price 6.62 per share. | 130K | $861.07K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.4 | 0.3 | -4.5 | 6.0 | 2.8 | 4.1 | -5.4 | 2.8 | -4.8 | -10.0 | −7.3% | ||
| 2025 | 1.6 | 12.2 | -0.6 | -11.5 | -17.8 | 9.0 | -3.6 | 12.3 | -10.1 | -8.9 | 8.0 | 1.7 | −12.6% |
| 2024 | -8.9 | -11.5 | -2.2 | -7.3 | 14.5 | -2.3 | 5.2 | -2.5 | 6.4 | -8.3 | -2.2 | -13.2 | −30.5% |
| 2023 | 18.5 | -10.4 | -9.4 | 1.9 | -6.0 | 4.7 | 8.4 | -2.2 | -7.3 | -3.5 | 15.8 | 10.7 | +17.1% |
| 2022 | -4.7 | -7.2 | 3.9 | -9.6 | -11.9 | -13.6 | 8.5 | -11.0 | -21.4 | 7.3 | 10.5 | -6.1 | −46.6% |
| 2021 | -4.0 | 7.4 | -2.7 | 9.5 | 0.3 | 2.5 | 5.4 | -0.9 | -4.7 | 12.8 | -1.4 | 8.6 | +35.9% |
| 2020 | 10.4 | -4.3 | -27.6 | 3.0 | 2.9 | 5.7 | 4.9 | 7.6 | 5.6 | -7.9 | 10.1 | -4.6 | −1.3% |
| 2019 | 7.9 | 7.4 | -4.7 | 3.9 | 4.5 | -1.5 | -1.6 | 5.8 | 4.3 | 6.1 | 15.0 | -5.0 | +48.8% |
| 2018 | -2.2 | -19.0 | 6.9 | 12.1 | 14.8 | -0.9 | -4.6 | 13.3 | -1.6 | -2.8 | 3.4 | -6.1 | +8.4% |
| 2017 | -0.8 | -5.1 | 8.1 | 2.1 | 0.2 | -3.8 | 4.0 | -9.1 | 6.3 | -5.8 | 12.8 | -14.0 | −8.1% |
| 2016 | 8.0 | -1.6 | -9.2 | -0.1 | -25.0 | 22.0 | −11.8% |
Chiron is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Chiron Real Estate Inc. was established in 2011 and was incorporated in Maryland.
Buy / hold / sell counts